Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

4.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
4.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.3K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

222
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
222

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

American journal of respiratory and critical care medicine·2026
Same author

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Carbocisteine or Hypertonic Saline for Acute Respiratory Failure.

The New England journal of medicine·2026
Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026
Same author

Remote Multicomponent Rehabilitation in Intensive Care Unit Survivors: A Randomized Clinical Trial.

JAMA·2026
Same author

Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.

The Lancet. Respiratory medicine·2026
Same journal

British Thoracic Society quality standard for pulmonary rehabilitation.

BMJ open respiratory research·2026
Same journal

Maternal, Infant, Reproductive and Child Health in Cystic Fibrosis (MATRIARCH_CF): a prospective, observational study to evaluate pregnancy and parenthood in females with cystic fibrosis and health of the offspring in the CFTR-modulator era.

BMJ open respiratory research·2026
Same journal

Maternal asthma activity and offspring asthma: a linked-data population study in Australia and Sweden.

BMJ open respiratory research·2026
Same journal

Efficacy and safety of RApid PrednIsolone Dose reduction for acute exacerbation of Idiopathic Pulmonary Fibrosis (RAPID-IPF Trial): a study protocol for a randomised controlled trial.

BMJ open respiratory research·2026
Same journal

GOLD 2026 COPD ABE assessment tool to identify individuals at high risk in a UK multicentre COPD cohort (ERICA).

BMJ open respiratory research·2026
Same journal

Current use and future potential of oscillometry in UK lung function testing: a national survey.

BMJ open respiratory research·2026
See all related articles

Related Experiment Video

Updated: Sep 9, 2025

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.8K

Improving shared decision-making in bronchiectasis.

Paul McCallion1,2, Judy M Bradley3, Adam Lewis4

  • 1Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK paul.mccallion@nhs.net.

BMJ Open Respiratory Research
|September 3, 2025
PubMed
Summary
This summary is machine-generated.

Personalized medicine in bronchiectasis is growing. Shared decision-making (SDM) can improve patient choice and adherence to airway clearance techniques (ACTs), essential non-pharmacological treatments.

Keywords:
Bronchiectasis

More Related Videos

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

795
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

528

Related Experiment Videos

Last Updated: Sep 9, 2025

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting
04:47

Author Spotlight: Learning Systematic Bronchoscopy in a Simulation-Base Setting

Published on: June 23, 2023

2.8K
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

795
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

528

Area of Science:

  • Pulmonology
  • Personalized Medicine
  • Health Psychology

Background:

  • Bronchiectasis is a complex lung condition requiring individualized treatment.
  • Current management includes pharmacological and non-pharmacological approaches like airway clearance techniques (ACTs).
  • Patient adherence to ACTs is variable, highlighting a need for improved personalization.

Purpose of the Study:

  • To explore the role of shared decision-making (SDM) in personalizing ACT prescriptions for bronchiectasis.
  • To investigate how SDM can enhance patient choice and adherence to ACTs.
  • To outline steps for developing an SDM intervention for ACTs in bronchiectasis.

Main Methods:

  • Literature review on personalized medicine and SDM in bronchiectasis.
  • Discussion of current guidelines and challenges in ACT prescription.
  • Conceptual framework for an SDM intervention.

Main Results:

  • Existing literature lacks focus on patient preference in ACT prescription for bronchiectasis.
  • SDM offers a framework to integrate patient choice into ACT selection and adherence.
  • An SDM intervention could empower patients and improve engagement with ACTs.

Conclusions:

  • Shared decision-making (SDM) holds significant potential for personalizing airway clearance techniques (ACTs) in bronchiectasis.
  • Implementing SDM can empower patients, improve understanding of ACT importance, and enhance adherence.
  • Further research is needed to develop and evaluate SDM interventions for ACTs in bronchiectasis.